NEEDS REVIEW
As of October 9, 2026 at 2:28 AM, this is how Optics News reads the wording differences in this story.
What happened Medsafe approved two psychiatrists to prescribe MDMA for PTSD in September.
The headline split The headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidence Developing. Only 2 sources are matched, and the source map is still narrow. Useful to watch, not enough to draw conclusions yet.
Same-event confidenceDevelopingNot enough sources yet to confirm this is the same specific event.
Framing confidenceHiddenWording-gap score not shown — same-event match is still developing.
Wording differs, but the match is too narrow to read confidently yet.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.Optics keeps watching for pickup.
CenterNZX-listed company to import therapeutic MDMAThe New Zealand Herald · Center · News report
Right / center-rightNo matching source in this bucket yet.Optics keeps watching for pickup.
SEE THE HEADLINES
NZX-listed company to import therapeutic MDMA
Medsafe approved two psychiatrists to prescribe MDMA for PTSD in September.
Open sourceNZX-listed company to import therapeutic MDMA
MDMA, also known as "molly" or "ecstasy" when used recreationally, can be used in a medical setting to treat PTSD.
Open sourceDetailsScore hidden · 2 sources · 1 bias buckets
Score hidden until the match is cleanerLow confidence2 sources · 1 bias bucketsDeveloping · 2 sources · 1 bucketFormats: News report
SOURCE MAP CHANGES
Oct 9, 1:56 AM: Radio New Zealand joined the source map.
Oct 9, 2:28 AM: The New Zealand Herald joined the source map.
Now: score hidden until the source match is cleaner. Story health is developing · 2 sources · 1 bucket.